OPKO Health, Inc. (OPK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 10:22AM EDT. Market open.
| Previous Close | 1.2300 |
| Open | 1.2000 |
| Bid | 1.0400 x 100 |
| Ask | 1.3800 x 100 |
| Day's Range | 1.2000 - 1.2300 |
| 52 Week Range | 0.8500 - 2.2400 |
| Volume | |
| Avg. Volume | 9,128,137 |
| Market Cap | 839.875M |
| Beta (5Y Monthly) | 1.84 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2500 |
| Earnings Date | May 01, 2024 - May 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.25 |
ZacksOPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
OPKO Health (OPK) expects to re-establish profitability in its clinical laboratory business via its latest efforts to streamline its laboratory services business.
- Zacks
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
The recent deal will augment Labcorp's (LH) laboratory services network and expand access to the company's high-quality clinical laboratory services.
PR NewswireLabcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
© 2024 Yahoo. All rights reserved.